VEGF Receptor 3 Monoclonal Antibody (4H4), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA515651-Each-of-1 | In Stock | ₹ 49,795.50 |
PIMA515651 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 49,795.50
GST (18%): ₹ 8,963.19
Total Price: ₹ 58,758.69
Antigen
VEGF Receptor 3
Classification
Monoclonal
Concentration
Conc. Not Determined
Formulation
ascites with 0.03% sodium azide
Gene Accession No.
P35916
Gene Symbols
FLT4
Immunogen
Purified recombinant fragment of human FLT4 expressed in E. Coli.
Regulatory Status
RUO
Gene ID (Entrez)
2324
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
ELISA, Immunocytochemistry, Western Blot
Clone
4H4
Conjugate
Unconjugated
Gene
FLT4
Gene Alias
AI323512; Chy; chylous ascites; Flt4; FLT-4; FLT41; fms related tyrosine kinase 4; FMS-like tyrosine kinase 4; fms-related tyrosine kinase 4; LMPH1A; PCL; receptor protein tyrosine kinase; soluble VEGFR 3; sVEGFR 3; tyrosine-protein kinase receptor FLT4; Vascular endothelial growth factor receptor 3; vascular endothelial growth factor receptor-3; VEGF R3; VEGFR3; VEGFR-3
Host Species
Mouse
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG1
Related Products
Description
- MA5-15651 targets FLT4 in indirect ELISA, WB applications and shows reactivity with Human samples
- The MA5-15651 immunogen is purified recombinant fragment of human FLT4 expressed in E
- Coli.<br>
- MA5-15651 detects FLT4 which has a predicted molecular weight of approximately 145kDa
- Vascular endothelial growth factor is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues
- Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specificl ymphatic endothelial receptor VEGFR-3
- In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos
- Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5
- Thus, VEGFR3 has an essential role in the development of theembryonic cardiovascular system before the emergence of the lymphatic vessels.